HERVOLUTION Therapeutics appoints Moderna Co-Founder and MIT Professor Robert S. Langer as Chair of its Scientific Advisory Board
COPENHAGEN, Denmark, Sept. 13, 2023 /PRNewswire/ -- HERVOLUTION Therapeutics (HERVOLUTION) (formerly InProTher ApS), an early-stage biotechnology company developing effective cancer immunotherapies targeting Human Endogenous Retroviruses (HERVs), today announces the appointment of Professor Robert S. Langer, Sc D., as Chair of its Scientific Advisory Board (SAB).
- COPENHAGEN, Denmark, Sept. 13, 2023 /PRNewswire/ -- HERVOLUTION Therapeutics (HERVOLUTION) (formerly InProTher ApS), an early-stage biotechnology company developing effective cancer immunotherapies targeting Human Endogenous Retroviruses (HERVs), today announces the appointment of Professor Robert S. Langer, Sc D., as Chair of its Scientific Advisory Board (SAB).
- Professor Robert S. Langer, newly appointed Chair of HERVOLUTION's Scientific Advisory Board, commented: "Oncology needs a paradigm shift.
- Dr Peter Holst, Founder and Chief Scientific Officer of HERVOLUTION, said: "We are honoured to welcome Professor Langer as Chair of HERVOLUTION's Scientific Advisory Board.
- Prof Langer is the co-founder of Moderna Therapeutics and Professor at the Massachusetts Institute of Technology (MIT).